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The primary goal of palliative cancer care is to improve, or main-
tain, patients’ health-related quality of life (HRQL). Subjective
outcome measures including physical, psychological and social
well-being are therefore frequently used to assess the effect of
palliative care interventions (Smeenk et al, 1998; Salisbury et al,
1999). Population-based studies, however, have shown that patient
characteristics such as age, gender, marital status and diagnoses
may have a profound impact on HRQL-ratings (Brazier et al,
1992; Jenkinson et al, 1993; Klee et al, 1997; Hjermstad et al,
1998a, 1998b). Hence, HRQL outcomes may be confounded by
such factors, which consequently need consideration in study
design and statistical analyses as well as in the comparison of
results among different trials. This is particularly relevant in
palliative care research, where the target population is generally
very heterogeneous, and the patient selection may vary substan-
tially from one setting to another (Hearn and Higginson, 1998;
Wilkinson, 1999). 
However, HRQL may change with time and circumstances, and
what has been found to influence the HRQL in population-based
surveys, may not be valid among patients who are severely ill
(Cohen and Mount, 1992). The main purpose of this study was
therefore to explore the impact of sociodemographic and medical
characteristics on the HRQL of patients with incurable cancer and
short survival expectancy. The HRQL assessments were made
using the EORTC QLQ-C30 questionnaire (Aaronson et al, 1993). 
According to normative data (Hjermstad et al, 1998a), older
people report worse functioning and more symptoms than those
who are younger. This may mainly be related to comorbidity
(Moum, 1992; Hjermstad et al, 1998b; Michelson et al, 2000), and
as HRQL has been found to vary with clinical criteria such as
performance status and prognoses (Osoba et al, 1994; King, 1996),
our hypothesis was that the level of functioning impairment and
symptom level among our patients would depend on disease-
related factors rather than age. One exception was assumed. Older
persons with cancer have been found to manifest fewer and less
severe psychosocial problems (Mor et al, 1994), thus, we postu-
lated that emotional functioning would be better among the oldest.
Overall, having higher education, being male or being married
rather than living alone have been found to exert a positive influ-
ence on HRQL (Sullivan et al, 1994; Hjermstad et al, 1998a;
Michelson et al, 2000). Similar findings were expected among
advanced cancer patients. In particular, we found it reasonable to
believe that having a partner would be important to their sense of
well-being and emotional and social functioning. 
MATERIAL AND METHODS 
Design and study sample 
The study sample originated from a cluster randomised trial
comparing the service of the Palliative Medicine Unit at the
University Hospital of Trondheim, Norway to conventional care. The
design, recruitment and outcome measures have been thoroughly
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described elsewhere (Jordhoy et al, 1999, 2000). Inclusion criteria
were incurable, malignant disease, life expectancy between 2 and 9
months and age above 18. Completion of the baseline HRQL assess-
ment, which included the EORTC QLQ-C30 questionnaire, was
mandatory for trial entry (Jordhoy et al, 1999). 
Between March 1995 and November 1997, 434 patients were
entered onto trial, of whom 16 patients withdrew while 23 were
still alive at the end of follow-up (2 years). A total of 395 patients
died, and to be able to take time from assessment to death into
account, only these patients were included in the present study
sample. Median age was 70 years, 47% was female, and the
majority was living with their spouse (Table 1). Education was
recorded as number of years at school. ‘Seven years’ was the
minimum educational requirement up to 1968. After this, the
public compulsory education was increased by 2 more years. More
than 13 years corresponds to studies at the university level (Table
1). Neither former nor present type of occupation was recorded. At
trial entry, only 10 patients (2.5%) were still working. Thus,
exploring any impact of working status would not be meaningful.
Cancers of the digestive system were the most frequent diagnoses,
and 41% of the patients had a Karnofsky performance status of 70
or less (Table 1). Median survival was 13 weeks (range 0–125
weeks). 
For the purpose of this study, EORTC QLQ-C30 scores obtained
at trial entry were analysed. Due to death or withdrawal, the sample
size decreased during the follow-up, hence the baseline scores were
chosen to achieve the best statistical power. These scores were also
considered to be the most appropriate for the analyses because
some relevant medical characteristics (e.g. performance status and
location of metastasis) were only recorded at enrolment. 
The EORTC QLQ-C30 questionnaire 
The EORTC QLQ-C30 questionnaire (Aaronson et al, 1993; Fayers
et al, 1995; Kaasa et al, 1995) includes a total of 30 items and is
composed of scales that evaluate physical (5 items), emotional
functioning (4 items), role (2 items), cognitive (2 items) and social
(2 items) functioning as well as global health status (2 items).
Higher mean scores on these scales represent better functioning.
The questionnaire also comprises 3 symptom scales measuring
nausea and vomiting (2 items), fatigue (3 items) and pain (2 items),
and 6 single items assessing financial impact and various physical
symptoms. Higher scores on these scales/items mean more symp-
toms. Before statistical analyses, the raw EORTC QLQ-C30 scores
are linearly transformed to a 0–100 scale (Fayers et al, 1995). A
mean change in scores of 5 to 10 has been found to represent ‘a
little’ subjective change to the patients, while a change of 10 to 20
represents a moderate change (Osoba et al, 1998). Thus, differences
of 10 points or more may be regarded as clinically significant. 
Missing items were imputed by the method advocated by the
EORTC QLQ research group; if at least half of the items from a
scale were completed, the mean value for these items was imputed
for those missing (Fayers et al, 1995). The overall proportion of
missing items was 1.5%. 
Statistics 
HRQL scores were compared between subgroups according to
patients’ sociodemographic and medical characteristics using
Students’ t-test and one-way analyses of variance (ANOVA). Post
hoc, and for characteristics including more than 2 nominal cate-
gories, multiple comparisons with Bonferroni adjustment were
used to identify differing subgroups, whereas for factors with
ordered categories, that is, categories defined according to perfor-
mance status, years of education, age and closeness to death,
differences were tested for linear trends (equivalent to linear
regression) (Altman 1991). 
Thereafter, the impact of sociodemographic and medical factors
on symptom and functioning scores was explored by multivariate
linear regression, starting with models including all explanatory
variables listed in Table 1, except marital status. The latter was
closely linked to living situation and therefore not analysed.
Living situation and performance status were dichotomised
(‘living with a spouse’, yes/no; Karnofsky status > 70, yes/no),
whereas for diagnoses and education, dummy variables were
created. Age was included as a continuous measure. A backward
stepwise approach was then used to build models excluding
factors that did not contribute significantly to the HRQL scores.
Finally, to explore if the non-eliminated factors maintained their
predictive significance when closeness to death was allowed for,
or if closeness to death itself was associated with the HRQL
Table 1 Patients’ sociodemographic and medical characteristics 
All patients 
(n = 395) 
n % 
Gender 
females 184 46.6 
males 211 53.4 
Age (years)
median (min–max) 69.5 (37–93) 
Married or cohabitating 
yes 251 63.5 
no 144 36.5 
Living situation 
alone 127 32.2 
with spouse or partner +/– children 249 63.0 
with others 19 4.8 
Education 
≤ 7 years 141 35.7 
8–10 years 140 35.4 
11–12 years 56 14.2 
≥ 13 years 58 14.7 
Cancer origin 
Gastro-intestine 168 42.5 
Lung 48 12.2 
Breast and female genitals 57 14.4 
Prostate and male genitals 36 9.1 
Others 86 21.8 
Weeks from diagnosis to 
inclusion-median (min-max) 36  (1–1469) 
Karnofsky status 
100 43 10.9 
90 93 23.5 
80 98 24.8 
70 79 20.0 
60 52 13.2 
50 23 5.8 
40 7 1.8 
< 40 0 0.0 
Skeletal metastasis 85 21.5 
Lung metastasis 61 15.4 
Liver metastasis 139 35.2 
Ongoing chemotherapy 52 13.2 
Ongoing radiotherapy 42 10.6 scores, time from assessment to death was added to the models,
and the backward stepwise procedure was repeated. 
The described statistical methods assume normal distribution of
the data. For most of the multi-item EORTC QLQ-C30 scales this
represented a reasonable approximation, and for the ease of inter-
pretation, the results according to these methods are presented.
However, non-parametric tests and ordered logistic regression
were used to confirm all results, and any discrepancies are explic-
itly stated. 
The regression modelling was done by Stata version 5 (Stata
Corporation, 1997), otherwise SPSS version 9.0 (SPSS Inc, 1999)
was used. The P value for significance was set at P = 0.01 to
provide some protection from multiple comparisons. For the
multiple regression, time factors were treated as continuous vari-
ables, that is, the logarithms of time from diagnoses to assessment
(Table 1) and of time from assessment to death were used. 
RESULTS 
HRQL according to sociodemographic factors,
diagnoses and location of metastasis 
Very few patients (n = 33) were below 50 years of age, thus age
was categorised as in Table 2. Older age was significantly associ-
ated with better emotional and social functioning, less sleeping
disturbance and a lower financial impact (Table 2). The oldest
patients also tended to report more appetite loss, while most pain
was found among the youngest. These differences, however, were
not statistically significant. 
The EORTC scores according to gender and living situation are
shown in Table 3. Overall, men reported better functioning and
lower level of symptoms, but the differences were minor
and statistically significant only for physical functioning, fatigue
and nausea/vomiting. The results of comparing those who were
living with their spouse to those not doing so were similar to
comparing those who were living with someone to those who were
alone. In both cases, there was a significantly lower social func-
tioning among the former group (mean 45 with spouse/partner
versus 54 without). Otherwise, no statistically or clinically signifi-
cant differences were found. 
None of the EORTC QLQ-C30 scales/items differed signifi-
cantly according to levels of education (data not shown). However,
better emotional functioning (72 versus 65) was indicated among
patients with university education compared to those having 7
years at school or less. The former group also had the lowest pain
scores, whereas patients with a median level of education reported
poorer general well-being than those with both highest and lowest
level (35 versus 43 and 42). 
ANOVA tests comparing subgroups according to diagnoses
revealed significant differences for physical functioning, dysp-
noea, diarrhoea and constipation (P < 0.01) (Table 3). Patients
with gastro-intestinal cancer reported the best physical func-
tioning, and significantly better than those having cancer of the
breast and female genitals, and except for the latter group, patients
with lung cancer reported significantly more dyspnoea than the
others (P < 0.01, Bonferroni) (Table 3). Most diarrhoea and least
constipation were reported among patients with gastrointestinal
cancers. For these scores, however, post hoc tests failed to identify
any subgroup differences within the defined level of significance. 
Patients with skeletal metastasis had significantly lower phys-
ical functioning, more pain and constipation than the others
(Table 3). Liver metastases were associated with lower pain and
constipation scores whereas patients with metastasis to the lungs
tended to report more dyspnoea (P = 0.02, ns) (Table 3). Overall,
patients who were on chemotherapy reported worse functioning
and more symptoms than those who were not, however, few differ-
ences were statistically significant (Table 3). 
HRQL scores according to closeness to death 
To explore the association between the HRQL scores and survival,
the patients were grouped according to time from assessment to
death. The scores of those patients who completed the baseline
1480 MS Jordhøy et al
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Table 2 EORTC QLQ-C30 functioning and symptom scores according to age 
All patients < 50 years 50–59 years 60–69 years 70–79 years 80 > years 
(n = 395) (n = 33) (n = 59) (n = 110) (n = 135) (n = 58) 
mean (SD) mean mean mean mean mean 
Functioning scales 
Physical 46 (31) 46 54 47 46 35 
Emotionala 66 (26) 56 59 64 68 76 
Role 32 (31) 24 32 29 34 33 
General well-being 39 (26) 36 40 38 40 38 
Cognitive 72 (27) 66 70 75 70 76 
Sociala 48 (33) 38 36 47 53 58 
Symptom scales 
Fatigue 65 (27) 67 64 64 62 72 
Nausea/vomiting 25 (30) 19 22 28 23 30 
Pain 48 (36) 59 53 46 46 48 
Single items 
Diarrhoea 26 (34) 23 26 27 28 22 
Dyspnoea 39 (36) 46 45 42 37 33 
Appetite 51 (39) 43 43 51 51 61 
Sleeping disturbancea 40 (36) 59 45 39 34 40 
Constipation 43 (39) 49 44 40 40 48 
Financial impacta 16 (27) 28 19 17 14 9 
aFor these scales the differences in scores between age groups were statistically significant (ANOVA, P = < 0.01), and a significant linear trend
across subgroups was found (P < 0.01). Quality of life and patients’ characteristics 1481
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questionnaire within 1, 2, 3, 4 and 5 months or more prior to death
respectively were compared. Between these groups, significant
differences (P < 0.005) were found on all functioning scales except
social functioning (P = 0.016) as well as on appetite loss, dysp-
noea, fatigue, nausea /vomiting, pain and constipation. For the
same scales/items, social functioning included, there was also a
significant linear trend across subgroups (P < 0.002) (Figure 1).
Overall, the worse scores were obtained within the last month of
life, whereas those patients who lived for 91–120 days or more
reported the best functioning and least symptoms. These differ-
ences were also clinically significant, that is, varying from 11
(emotional functioning) to 38 points (appetite loss). No association
between closeness to death and diarrhoea or sleeping disturbances
was found. 
HRQL scores according to performance status 
Performance status was measured using the Karnofsky index. For
all functioning and symptom scores, the worse ratings were
obtained from patients with the poorest status. The difference
between subgroups (Karnofsky index 40 to 100) (Table 1) was
statistically significant for all functioning scales except emotional
functioning, as well as for fatigue, pain, appetite loss and constipa-
tion (P < 0.002). Emotional functioning included, these scores also
showed a significant linear trend across subgroups (emotional
functioning: P = 0.006; others: P < 0.001), that is, better perfor-
mance status was associated with better scores and poorer status
with worse scores (Figure 2). As can be noted, the scores on social,
role and physical functioning as well as general well-being among
patients with Karnofsky status of 40 were very low, indicating a
‘floor effect’, or a poor ability to discriminate between subgroups
of such patients. Diarrhoea, sleeping disturbances and dyspnoea
showed minor variations, whereas subgroup differences in nausea
and vomiting scores were close to significant (P = 0.011) and
showed a significant linear trend (P = 0.001) (Figure 2). 
The difference in HRQL ratings between groups classified
according to whether Karnofsky status was more than 70 or not,
were also statistically significant (P < 0.002) for the same scales
and items as above, and for nausea and vomiting (P = 0.004). 
Factors contributing to HRQL scores according to
multivariate analyses 
The patients’ characteristics that according to multivariate linear
regression were predictive of the various EORTC QLQ-C30
symptom and functioning scores are presented in Table 4.
Consistent with the results of simple comparisons, gender was
predictive for physical functioning. The association between
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older age and better emotional and social functioning, lower pain
scores and less sleeping disturbances was confirmed. Allowing
for performance status, older age was also correlated to a better
role functioning. The only impact of living with a spouse was
worse social functioning scores (Table 4), whereas higher educa-
tion was associated with less pain, better emotional functioning
and greater general well-being. Except for physical functioning,
neither diagnoses, location of metastases or ongoing cancer
therapy were predictive of any functioning scores, whereas one
or more of these factors contributed to most symptom ratings
(Table 4). 
Adding time from assessment to death to the models cited in
Table 4, no factor was eliminated, except for level of education for
general well-being and performance status for both nausea and
vomiting and constipation (Table 4). Changes of the regression
coefficient and p-value of individual factors were minor. However,
time from assessment to death was found to make a significant
contribution to all models (social functioning: P = 0.006, the
others; P < 0.001) apart from those predicting emotional func-
tioning, diarrhoea and sleeping disturbances. Hence, performance
status and closeness to death were both significantly and indepen-
dently associated with fatigue, pain, appetite loss and all func-
tioning scales, except emotional functioning. The regression
coefficient of the time variable within the models varied from
–4.64 (pain) to –9.76 (appetite loss) for the symptom scores and
from 3.61 (social) to 5.83 (physical) for the functioning scores.
The contribution of variance from adding time from assessment to
death is shown in Table 4. 
Using ordered logistic regression, gender (P = 0.006) was
included into the model for nausea and vomiting instead of
Karnofsky status and was also not eliminated when allowing for
time from assessment to death. For the model predicting constipa-
tion, having lung metastases was excluded. Otherwise identical
results were achieved. 
Table 4 Linear regression models including sociodemographic and medical factors predictive of HRQL scores among advanced cancer patients 
Outcome variable Factors contributing  Estimates for individual  Estimate for Estimate for model
to outcome = model factors within model modela when factor ‘time 
from assessment to death’ 
Coef. SE P-value R-square was added R-square 
Functioning scales 
Physicalb Female sex – 9.6 2.7 < 0.001 0.30 0.35 
Lung cancer – 12.8 4.0 0.002 
Karnofsky status > 70 30.5 2.7 < 0.001 
Emotional Age 0.7 0.1 < 0.001 0.10 
≥ 13 years of education 11.2 3.6 0.002 
Karnofsky status > 70 11.3 2.7 < 0.001 
Roleb Age 0.5 0.1 < 0.001 0.14 0.18 
Karnofsky status > 70 24.0 3.1 < 0.001 
General well-beingb,c ≤ 7 years of educationd 7.7 2.5 0.005 0.13 0.18 
≥ 13 years of educationd 9.9 3.7 0.007 
Karnofsky status > 70 17.7 2.5 < 0.001 
Cognitiveb Karnofsky status > 70 11.9 2.7 < 0.001 0.05 0.09 
Socialb Age 0.8 0.2 < 0.001 0.14 0.15 
Living with spouse – 8.9 3.4 0.008 
Karnofsky status > 70 20.0 3.3 < 0.001 
Symptom scales/items 
Fatigueb Diagnoses ‘other’– 9.8 3.1 0.002 0.11 0.20 
Karnofsky status > 70 – 16.9 2.6 < 0.001 
Nausea/vomitingc Karnofsky status > 70d – 8.9 3.1 0.004 0.02 0.05 
Painb Age – 0.6 0.2 < 0.001 0.13 0.15 
Skeletal metastasis 17.8 4.2 < 0.001 
Karnofsky status > 70 – 17.4 3.7 < 0.001 
≥ 13 years of education – 14.1 4.8 0.004 
Diarrhoea Gastrointestinal cancer 13.0 3.4 < 0.001 0.04 
Dyspnoeab Lung cancer 31.2 5.6 < 0.001 0.11 0.13 
Cancer of breast/female genitals 18.7 5.0 < 0.001 
Lung metastasis 12.6 4.9 0.01 
Appetite lossb Karnofsky status > 70 – 16.9 4.0 < 0.001 0.05 0.13 
Sleeping disturbances Age – 0.4 0.2 0.007 0.02 
Constipationb,c Ongoing radiotherapy 19.4 6.2 0.002 0.09 0.11 
Ongoing chemotherapy 19.8 5.6 < 0.001 
Lung metastasis – 15.1 5.3 0.005 
Karnofsky status > 70d – 12.9 3.9 0.001 
aP < 0.001 for all models except for nausea/vomiting, P = 0.004 and for sleeping disturbances, P = 0.007. 
boutcomes to which ‘time from assessment to death’ = ‘closeness to death’ contributed significantly in multivariate model. 
coutcomes to which ‘time from assessment to death’ contributed significantly, but where this factor eliminated others from the multivariate model. 
dfactors that were eliminated from model when ‘time from assessment to death’ was added. 1484 MS Jordhøy et al
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DISCUSSION 
The most striking result that emerges from the study, was the asso-
ciation between the HRQL ratings and performance status and
closeness to death. Other clinical criteria such as diagnoses and
location of metastasis contributed significantly to most symptom
scores, whereas the overall influence of sociodemographic charac-
teristics seemed less important. 
Declining HRQL scores with physical deterioration and prior to
death is consistent with the results of others (Morris et al, 1986;
King, 1996; Axelsson and Sjoden, 1998). In this study, however,
performance status and time from assessment to death were found
to be independent contributors to most functioning scores.
Although the finding does not contradict reports on HRQL scores
being predictive of survival (Coates et al, 1997), it might be ques-
tioned whether such scores carry true prognostic information, or if
they are mainly dependent on time of assessment due to an
inevitable decline as death is approached. Anyway, our results
confirm the necessity of taking differences in survival into account
when comparing HRQL scores across settings and studies
(Salisbury, 1999). Even in randomised studies of palliative care
interventions, differences in HRQL scores might be related to
differences in time from assessment to death rather than being a
treatment effect, that is, if survival is not comparable among treat-
ment groups. 
As hypothesised and also reported by others (Klee et al, 1997;
Michelson et al, 2000), older age was associated with better
emotional functioning. In addition, age was predictive to role func-
tioning, pain and sleeping disturbances, and opposed to results from
a Norwegian population based survey (Hjermstad et al, 1998a), the
impact of being old was merely positive. The observed differences
between genders were consistent with normative EORTC QLQ-
C30 data (Hjermstad et al, 1998a). In both samples, most differ-
ences were below clinical significance (less than 10). Compared to
the larger population surveys, the present sample size was small,
which could be the reason why in this study, most differences were
also not statistically significant. The same explanation may be
proposed for not detecting any overall positive impact of having a
partner or higher education, as reported from general populations
(Hjermstad et al, 1998a; Michelson et al, 2000). On the other hand,
detailed analysis of population based data on self assessed health
have also suggested that the contribution of such factors may be
marginal when fine-grained arrays of medical information is taken
into account (Moum, 1994). Our finding is, however, contradictory
to the palliative care theory and experience, namely that living situ-
ation is of great importance to the patients’ well-being. Further
research on these issues seems necessary. 
Surprisingly, being younger and living with a spouse were found
to have a negative influence on social functioning. The explanation
can be found in the wordings of the items within this scale. It is
asked if physical condition or medical treatment has affected the
respondents’ family life and social activity. Patients, who are living
alone or have low social activity in the first place, may be likely to
answer ‘not at all’ and thus, obtain higher scores. Answering the
questions also gives no indication whether a change is for the worse
or for the better, hence these items do not seem to be an entirely
useful measure of cancer patients’ present social functioning. 
The EORTC QLQ-C30 questionnaire was not developed for
palliative care in particular and its appropriateness within these
settings has been queried (Donelly and Walsh, 1996; Hearn and
Higginson, 1997). However, the questionnaire has been widely
used, rigorously developed, extensively tested, and its validity and
reliability and responsiveness to changes have been established
among advanced cancer patients (Kaasa et al, 1995; Cunningham
et al, 1998). Although our results mainly confirm its ability to
discriminate between groups of such patients, the floor effect that
was observed on some functioning scale when Karnofsky status
declined to 40, might be an indication that the questionnaire is not
appropriated for those patients who are most severely ill. 
Most of the regression models that were found to be predictive
of the various HRQL scales explained only a minor part of the
total variance. However, the coefficients of individual factors
within the models were large, e.g. for physical functioning a
decrease of ten in females compared to males was indicated,
whereas Karnofsky status above 70 would give an increase of
about 30. The multivariate analyses also confirmed the association
between HRQL and the factors, for which significant group differ-
ences were found by simple comparisons. Consistent results were
obtained by non-parametric statistics. Hence, we conclude that in
studies of advanced cancer patients using HRQL outcomes,
performance status, closeness to death, diagnoses and location of
metastases as well as age and gender need consideration, either in
design or in reporting of the findings. Living situation and educa-
tion may be less relevant. However, the present study were based
on data from a randomised trial evaluating a palliative care
programme, and larger studies which are specifically designed for
the purpose, may be needed to fully explore the impact of these
and other social factors. 
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